SC
ATRC icon

Scotia Capital’s AtriCure ATRC Stock Holding History

Scotia Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
41,495
+1,116
+3% +$31.4K ﹤0.01% 568
2026
Q1 		$1.15M Buy
40,379
+1,430
+4% +$48.8K ﹤0.01% 549
2025
Q4 		$1.54M Buy
38,949
+1,272
+3% +$46.6K 0.01% 502
2025
Q3 		$1.33M Buy
37,677
+457
+1% +$15.7K 0.01% 521
2025
Q2 		$1.22M Buy
37,220
+611
+2% +$19.9K 0.01% 499
2025
Q1 		$1.18M Buy
+36,609
New +$1.36M 0.01% 483

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Scotia Capital's ATRC Position: Q2 2026 in Review

Scotia Capital increased its AtriCure (ATRC) stake by 2.8% in Q2 2026, buying an estimated $31.4K and bringing the position to 41,495 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #568.

Scotia Capital first reported a position in ATRC in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.54M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Scotia Capital held 41,495 shares of AtriCure worth $1.16M as of Q2 2026.
  • Scotia Capital bought 1,116 AtriCure shares in Q2 2026, an estimated $31.4K.
  • AtriCure made up ﹤0.01% of Scotia Capital's portfolio in Q2 2026, its #568 holding.
  • Scotia Capital first reported a position in AtriCure in Q1 2025 and has held it in 6 quarters since.
  • Scotia Capital's AtriCure position peaked at $1.54M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.